Related Experiment Video
Updated: Jun 16, 2026

08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Deep3D-DTA: A Tri-Modal Deep Learning Framework for Binding Affinity Prediction Leveraging 3D Structural
Han Zhou1, Xiumin Shi2, Lu Wang3
1School of Information and Electronics, Beijing Institute of Technology, Beijing, 100081, China.
Interdisciplinary Sciences, Computational Life Sciences
|June 15, 2026
Summary
Deep3D-DTA, a new deep learning model, predicts drug-target affinity (DTA) using 1D, 2D, and 3D molecular data. This approach enhances drug discovery by providing more accurate predictions than existing methods.
Area of Science:
- Computational chemistry
- Bioinformatics
- Artificial intelligence in drug discovery
Background:
- Drug-target affinity (DTA) prediction is crucial for drug discovery and repurposing.
- Current computational methods often fail to capture complex molecular interactions due to reliance on limited data types (1D sequences or 2D structures).
Purpose of the Study:
- To introduce Deep3D-DTA, a novel tri-modal deep learning framework for accurate DTA prediction.
- To integrate diverse molecular representations (1D sequence, 2D graph, 3D spatial) for enhanced prediction accuracy.
Main Methods:
- Utilized a pre-trained protein language model for encoding 1D amino acid sequences.
- Generated precise 3D structural representations using interatomic distances and bond angles.
- Employed a hybrid feature extraction module combining graph neural networks and multi-head attention for hierarchical pattern learning.
Main Results:
- Deep3D-DTA significantly outperformed state-of-the-art methods on three benchmark datasets (Davis, KIBA, Metz).
- The tri-modal approach effectively captured complex molecular interactions for improved DTA prediction.
Conclusions:
- Deep3D-DTA offers a robust computational tool for accelerating drug discovery.
- Accurate DTA prediction using Deep3D-DTA can potentially reduce drug development costs.
Related Concept Videos
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
